The biology of the ABCA3 lipid transporter in lung health and disease

[1]  S. Kure,et al.  ABCA3 mutations led to pulmonary fibrosis and emphysema with pulmonary hypertension in an 8‐year‐old girl , 2016, Pediatric pulmonology.

[2]  R. Boldrini,et al.  ABCA3, a key player in neonatal respiratory transition and genetic disorders of the surfactant system. , 2015, Biochemical Society transactions.

[3]  M. Beers,et al.  Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[4]  G. Schmitz,et al.  ABCA3 protects alveolar epithelial cells against free cholesterol induced cell death. , 2015, Biochimica et biophysica acta.

[5]  J. Whitsett,et al.  Diseases of pulmonary surfactant homeostasis. , 2015, Annual review of pathology.

[6]  S. Kure,et al.  Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects , 2015, Clinical medicine insights. Circulatory, respiratory and pulmonary medicine.

[7]  J. Pérez-Gil,et al.  Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films. , 2015, Chemistry and physics of lipids.

[8]  J. Murray,et al.  Single mutations in ABCA3 increase the risk for neonatal respiratory distress syndrome in late preterm infants (gestational age 34–36 weeks) , 2014, American journal of medical genetics. Part A.

[9]  A. Hamvas,et al.  Genotype-phenotype correlations for infants and children with ABCA3 deficiency. , 2014, American journal of respiratory and critical care medicine.

[10]  J. Gonçalves,et al.  Novel ABCA3 mutations as a cause of respiratory distress in a term newborn. , 2014, Gene.

[11]  B. Uhal,et al.  The Witschi Hypothesis revisited after 35 years: genetic proof from SP-C BRICHOS domain mutations. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[12]  Ming Zhao,et al.  Disruption of N-linked glycosylation promotes proteasomal degradation of the human ATP-binding cassette transporter ABCA3. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[13]  S. Simon,et al.  Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations , 2013, European Respiratory Journal.

[14]  Michael J. Cronce,et al.  Type 2 alveolar cells are stem cells in adult lung. , 2013, The Journal of clinical investigation.

[15]  S. Kure,et al.  Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations , 2013, European Journal of Pediatrics.

[16]  Qunyuan Zhang,et al.  Single ABCA3 Mutations Increase Risk for Neonatal Respiratory Distress Syndrome , 2012, Pediatrics.

[17]  K. Conzelmann,et al.  Respiratory syncytial virus potentiates ABCA3 mutation-induced loss of lung epithelial cell differentiation. , 2012, Human molecular genetics.

[18]  L. Guillot,et al.  Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. , 2012, Human molecular genetics.

[19]  A. Hamvas,et al.  An intronic ABCA3 mutation responsible for respiratory disease , 2012, Pediatric Research.

[20]  J. Åqvist,et al.  High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C , 2012, Proceedings of the National Academy of Sciences.

[21]  L. Guillot,et al.  Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. , 2012, Human molecular genetics.

[22]  M. Dishop.  Paediatric interstitial lung disease: classification and definitions. , 2011, Paediatric respiratory reviews.

[23]  J. A. Maguire,et al.  A novel conserved targeting motif found in ABCA transporters mediates trafficking to early post-Golgi compartments[S] , 2011, Journal of Lipid Research.

[24]  A. Holzinger,et al.  Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells , 2011, Respiratory research.

[25]  A. Holzinger,et al.  Some ABCA 3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells , 2011 .

[26]  M. Griese,et al.  The surfactant lipid transporter ABCA3 is N‐terminally cleaved inside LAMP3‐positive vesicles , 2010, FEBS letters.

[27]  Peter F. Crossno,et al.  Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC. , 2010, Chest.

[28]  B. Nordestgaard,et al.  Two novel mutations in surfactant protein-C, lung function and obstructive lung disease. , 2010, Respiratory medicine.

[29]  W. Ladiges,et al.  Phenylbutyric Acid Rescues Endoplasmic Reticulum Stress-Induced Suppression of APP Proteolysis and Prevents Apoptosis in Neuronal Cells , 2010, PloS one.

[30]  B. Nordestgaard,et al.  Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers. , 2010, American journal of respiratory and critical care medicine.

[31]  V. Kos,et al.  The ATP-binding cassette family: a structural perspective , 2009, Cellular and Molecular Life Sciences.

[32]  J. Whitsett,et al.  Genetic Disorders of Surfactant Dysfunction , 2009, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[33]  R. Tubman,et al.  ABCA3 Deficiency: an unusual cause of respiratory distress in the newborn , 2009, The Ulster medical journal.

[34]  S. Guttentag.  Posttranslational regulation of surfactant protein B expression. , 2008, Seminars in perinatology.

[35]  N. Inagaki,et al.  Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[36]  T. Colby,et al.  Usual interstitial pneumonia in an adolescent with ABCA3 mutations. , 2008, Chest.

[37]  A. Hamvas,et al.  Population and Disease-Based Prevalence of the Common Mutations Associated With Surfactant Deficiency , 2008, Pediatric Research.

[38]  Peter F. Crossno,et al.  Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[39]  M. Montalembert.  Management of sickle cell disease , 1998, BMJ : British Medical Journal.

[40]  M. Sockrider,et al.  Clinical, radiological and pathological features of ABCA3 mutations in children , 2007, Thorax.

[41]  L. Bubendorf,et al.  Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation , 2007, Modern Pathology.

[42]  T. A. Parker,et al.  ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. , 2007, The Journal of pediatrics.

[43]  N. Cheong,et al.  ABCA3 Is Critical for Lamellar Body Biogenesis in Vivo* , 2007, Journal of Biological Chemistry.

[44]  M. D. de Angelis,et al.  Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies. , 2007, Biochemical and biophysical research communications.

[45]  L. Nogee,et al.  Heterozygosity for ABCA3 Mutations Modifies the Severity of Lung Disease Associated with a Surfactant Protein C Gene (SFTPC) Mutation , 2007, Pediatric Research.

[46]  Yoshihiro Matsumura,et al.  ABCA3‐mediated choline‐phospholipids uptake into intracellular vesicles in A549 cells , 2007, FEBS letters.

[47]  Donglei Zhang,et al.  Correctors of Protein Trafficking Defects Identified by a Novel High‐Throughput Screening Assay , 2007, Chembiochem : a European journal of chemical biology.

[48]  M. Molinari.  N-glycan structure dictates extension of protein folding or onset of disposal. , 2007, Nature chemical biology.

[49]  K. Linton.  Structure and function of ABC transporters. , 2007, Physiology.

[50]  H. Arai,et al.  ABCA3 as a Lipid Transporter in Pulmonary Surfactant Biogenesis* , 2007, Journal of Biological Chemistry.

[51]  R. Xavier,et al.  ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerols⃞ Published, JLR Papers in Press, December 1, 2006. , 2007, Journal of Lipid Research.

[52]  F. Reinholt,et al.  Novel mutations in the gene encoding ATP binding cassette protein member A3 (ABCA3) resulting in fatal neonatal lung disease , 2007, Acta paediatrica.

[53]  C. Albrecht,et al.  The ABCA subfamily—gene and protein structures, functions and associated hereditary diseases , 2007, Pflügers Archiv - European Journal of Physiology.

[54]  S. Wert,et al.  ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease. , 2006, Seminars in perinatology.

[55]  K. Ueda,et al.  Characterization and Classification of ATP-binding Cassette Transporter ABCA3 Mutants in Fatal Surfactant Deficiency* , 2006, Journal of Biological Chemistry.

[56]  D. Townsend,et al.  The ATP-binding cassette transporter ABCA2 as a mediator of intracellular trafficking. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[57]  O. K. Olstad,et al.  The human ortholog of the rodent testis-specific ABC transporter Abca17 is a ubiquitously expressed pseudogene (ABCA17P) and shares a common 5' end with ABCA3 , 2006, BMC Molecular Biology.

[58]  T. Langmann,et al.  Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. , 2006, American journal of respiratory and critical care medicine.

[59]  A. Hamvas,et al.  Surfactant Composition and Function in Patients with ABCA3 Mutations , 2006, Pediatric Research.

[60]  J. Wenzel,et al.  ABC A-subfamily transporters: structure, function and disease. , 2006, Biochimica et biophysica acta.

[61]  N. Cheong,et al.  Functional and Trafficking Defects in ATP Binding Cassette A3 Mutants Associated with Respiratory Distress Syndrome* , 2006, Journal of Biological Chemistry.

[62]  G. Tusnády,et al.  Membrane topology of human ABC proteins , 2006, FEBS letters.

[63]  N. Wüstneck,et al.  Interfacial properties of pulmonary surfactant layers. , 2005, Advances in colloid and interface science.

[64]  H Page McAdams,et al.  Clinical and pathologic features of familial interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.

[65]  J. Whitsett,et al.  ABCA3 mutations associated with pediatric interstitial lung disease. , 2005, American journal of respiratory and critical care medicine.

[66]  D. Kelsell,et al.  Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. , 2005, American journal of human genetics.

[67]  S. Guttentag,et al.  Defective surfactant secretion in a mouse model of Hermansky-Pudlak syndrome. , 2005, American journal of respiratory cell and molecular biology.

[68]  Michael F Beers,et al.  Surfactant protein C biosynthesis and its emerging role in conformational lung disease. , 2005, Annual review of physiology.

[69]  S. Russo,et al.  Nonspecific Interstitial Pneumonia, Alveolar Proteinosis, and Abnormal Proprotein Trafficking Resulting from a Spontaneous Mutation in the Surfactant Protein C Gene , 2005, Pediatric Research.

[70]  K. Ueda,et al.  Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles. , 2004, Biochemical and biophysical research communications.

[71]  K. Müller,et al.  Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene , 2004, European Respiratory Journal.

[72]  J. Whitsett,et al.  ABCA3 gene mutations in newborns with fatal surfactant deficiency. , 2004, The New England journal of medicine.

[73]  J. Oates,et al.  Herpesvirus DNA Is Consistently Detected in Lungs of Patients with Idiopathic Pulmonary Fibrosis , 2003, Journal of Clinical Microbiology.

[74]  S. Russo,et al.  Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative , 2003, Journal of Cell Science.

[75]  A. Fisher,et al.  Identification of LBM180, a Lamellar Body Limiting Membrane Protein of Alveolar Type II Cells, as the ABC Transporter Protein ABCA3* , 2002, The Journal of Biological Chemistry.

[76]  O. Kawanami,et al.  ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells1 , 2001, FEBS letters.

[77]  L. Galietta,et al.  Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. , 2001, American journal of physiology. Cell physiology.

[78]  V. Glumoff,et al.  Surfactant proteins A and D in Eustachian tube epithelium. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[79]  A. Helenius,et al.  Intracellular functions of N-linked glycans. , 2001, Science.

[80]  Joseph H. Nadeau,et al.  Modifier genes in mice and humans , 2001, Nature Reviews Genetics.

[81]  G. Dover,et al.  Sickle cell disease: no longer a single gene disorder. , 2001, Current opinion in pediatrics.

[82]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[83]  A. Fisher,et al.  Surface-expressed lamellar body membrane is recycled to lamellar bodies. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[84]  D. Perlmutter,et al.  Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[85]  P. Zeitlin,et al.  Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR. , 2000, American journal of physiology. Cell physiology.

[86]  D. Voelker,et al.  Trafficking of newly synthesized surfactant protein A in isolated rat alveolar type II cells. , 1998, American journal of respiratory cell and molecular biology.

[87]  J. J. Batenburg,et al.  The lipids of pulmonary surfactant: dynamics and interactions with proteins. , 1998, Progress in lipid research.

[88]  J. Slot,et al.  Generation and characterization of monoclonal antibodies to alveolar type II cell lamellar body membrane. , 1998, The American journal of physiology.

[89]  A. Verkman,et al.  A mouse model to test the in vivo efficacy of chemical chaperones. , 1998, Journal of pharmacological and toxicological methods.

[90]  J. Wright,et al.  Degradation of surfactant protein D by alveolar macrophages. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[91]  X. Yao,et al.  State of actin in gastric parietal cells. , 1998, American journal of physiology. Cell physiology.

[92]  J A Waldron,et al.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.

[93]  H. Bunn.  Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.

[94]  M. Yonemaru,et al.  Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. , 1997, The European respiratory journal.

[95]  U. Wolf.  Identical mutations and phenotypic variation , 1997, Human Genetics.

[96]  K. Klinger,et al.  The cloning of a human ABC gene (ABC3) mapping to chromosome 16p13.3. , 1997, Genomics.

[97]  N. Klugbauer,et al.  Primary structure of a novel ABC transporter with a chromosomal localization on the band encoding the multidrug resistance‐associated protein , 1996, FEBS letters.

[98]  A. Fisher,et al.  Surfactant protein A is degraded by alveolar macrophages. , 1996, The American journal of physiology.

[99]  A S Verkman,et al.  Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. , 1996, Cell stress & chaperones.

[100]  J. Wine,et al.  Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation (*) , 1996, The Journal of Biological Chemistry.

[101]  A. Tauber,et al.  Mouse surfactant protein-D. cDNA cloning, characterization, and gene localization to chromosome 14. , 1995, Journal of immunology.

[102]  A. Woodcock,et al.  Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. , 1995, Thorax.

[103]  J. Wright,et al.  Degradation of surfactant lipids and surfactant protein A by alveolar macrophages in vitro. , 1995, The American journal of physiology.

[104]  R. Mason,et al.  Expression of pulmonary surfactant protein D in rat gastric mucosa. , 1995, American journal of respiratory cell and molecular biology.

[105]  D. Schwartz,et al.  Determinants of progression in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.

[106]  E. Lander,et al.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.

[107]  S. Young,et al.  Recycling of surfactant lipid and apoprotein-A studied by electron microscopic autoradiography. , 1993, The American journal of physiology.

[108]  C. le Grimellec,et al.  Multiple modulation of Na-dependent Pi uptake by cellular Ca in MDCK cells. , 1993, The American journal of physiology.

[109]  J. J. Batenburg.  Surfactant phospholipids: synthesis and storage. , 1992, The American journal of physiology.

[110]  J. Wright,et al.  Regulation of pulmonary surfactant secretion and clearance. , 1991, Annual review of physiology.

[111]  J. Wright.  Clearance and recycling of pulmonary surfactant. , 1990, The American journal of physiology.

[112]  A. Fisher,et al.  Degradation of dipalmitoyl phosphatidylcholine by isolated rat granular pneumocytes and reutilization for surfactant synthesis. , 1987, The Journal of clinical investigation.

[113]  I. J. Evans,et al.  A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria , 1986, Nature.

[114]  A. Fisher,et al.  Intracellular processing of surfactant lipids in the lung. , 1985, Annual review of physiology.

[115]  L. Gluck,et al.  Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage. , 1981, The Journal of clinical investigation.

[116]  K. Keough,et al.  Exclusion of fluid lipid during compression of monolayers of mixtures of dipalmitoylphosphatidylcholine with some other phosphatidylcholines. , 1981, Biochimica et biophysica acta.

[117]  S. Schürch,et al.  Interference of bronchographic agents with lung surfactant. , 1976, Respiration physiology.

[118]  D H Bowden,et al.  Derivation of type 1 epithelium from type 2 cells in the developing rat lung. , 1975, Laboratory investigation; a journal of technical methods and pathology.

[119]  U. Ryan,et al.  Alveolar type II cells: studies on the mode of release of lamellar bodies. , 1975, Tissue & cell.

[120]  R. G. Shorter,et al.  Cell Turnover in Pulmonary Tissues , 1962, Nature.